Radiation-induced toxicity in cancer patients with low plasma fibronectin levels

Roxana G. Baluna, Clifton D. Fuller, Tony Y. Eng, Federico L. Ampil, Charles R. Thomas

Research output: Contribution to journalArticle

Abstract

The present study was carried out to evaluate the levels of plasma fibronectin (Fn) in cancer patients undergoing radiation therapy (RT) in correlation with outcomes in terms of radiation toxicity. A total of 26 patients with lung and gastrointestinal (GI) cancer, treated with RT were enrolled in this study. Plasma Fn levels were determined before and following a course of RT. The Radiation Therapy Oncology Group (RTOG) criteria were used to determine the grade of RT toxicity. Statistical analysis utilised the nonparametric Mann-Whitney U-test as well as bivariate linear regression. Pre-RT Fn levels were significantly higher in cancer patients without toxicity (median ± SE) (485.0 ± 87 μg/ml) as compared with the levels of plasma Fn in patients with grade I-II RTOG acute toxicity (354.0 ± 74 μg/ml, p = 0.01). No significant difference in Fn levels was found in patients with grade I toxicity compared with patients with grade II toxicity. In addition, low baseline Fn levels (148 and 299 μg/ml) were observed in two lung cancer patients who developed symptomatic pneumonitis during the first 2 months after RT. These preliminary results suggest that low baseline Fn may have potential as a predictive marker for development of RT-induced toxicity.

Original languageEnglish (US)
Pages (from-to)27-33
Number of pages7
JournalJournal of Radiotherapy in Practice
Volume10
Issue number1
DOIs
StatePublished - Mar 2011

Fingerprint

Fibronectins
Radiotherapy
Radiation
Neoplasms
Radiation Oncology
Lung Neoplasms
Gastrointestinal Neoplasms
Nonparametric Statistics
Linear Models
Pneumonia

Keywords

  • fibronectin
  • gastrointestinal cancer
  • lung cancer
  • radiation toxicity

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Oncology

Cite this

Radiation-induced toxicity in cancer patients with low plasma fibronectin levels. / Baluna, Roxana G.; Fuller, Clifton D.; Eng, Tony Y.; Ampil, Federico L.; Thomas, Charles R.

In: Journal of Radiotherapy in Practice, Vol. 10, No. 1, 03.2011, p. 27-33.

Research output: Contribution to journalArticle

Baluna, Roxana G. ; Fuller, Clifton D. ; Eng, Tony Y. ; Ampil, Federico L. ; Thomas, Charles R. / Radiation-induced toxicity in cancer patients with low plasma fibronectin levels. In: Journal of Radiotherapy in Practice. 2011 ; Vol. 10, No. 1. pp. 27-33.
@article{c62a693580284943a8a0518a8456cc76,
title = "Radiation-induced toxicity in cancer patients with low plasma fibronectin levels",
abstract = "The present study was carried out to evaluate the levels of plasma fibronectin (Fn) in cancer patients undergoing radiation therapy (RT) in correlation with outcomes in terms of radiation toxicity. A total of 26 patients with lung and gastrointestinal (GI) cancer, treated with RT were enrolled in this study. Plasma Fn levels were determined before and following a course of RT. The Radiation Therapy Oncology Group (RTOG) criteria were used to determine the grade of RT toxicity. Statistical analysis utilised the nonparametric Mann-Whitney U-test as well as bivariate linear regression. Pre-RT Fn levels were significantly higher in cancer patients without toxicity (median ± SE) (485.0 ± 87 μg/ml) as compared with the levels of plasma Fn in patients with grade I-II RTOG acute toxicity (354.0 ± 74 μg/ml, p = 0.01). No significant difference in Fn levels was found in patients with grade I toxicity compared with patients with grade II toxicity. In addition, low baseline Fn levels (148 and 299 μg/ml) were observed in two lung cancer patients who developed symptomatic pneumonitis during the first 2 months after RT. These preliminary results suggest that low baseline Fn may have potential as a predictive marker for development of RT-induced toxicity.",
keywords = "fibronectin, gastrointestinal cancer, lung cancer, radiation toxicity",
author = "Baluna, {Roxana G.} and Fuller, {Clifton D.} and Eng, {Tony Y.} and Ampil, {Federico L.} and Thomas, {Charles R.}",
year = "2011",
month = "3",
doi = "10.1017/S1460396910000154",
language = "English (US)",
volume = "10",
pages = "27--33",
journal = "Journal of Radiotherapy in Practice",
issn = "1460-3969",
publisher = "Cambridge University Press",
number = "1",

}

TY - JOUR

T1 - Radiation-induced toxicity in cancer patients with low plasma fibronectin levels

AU - Baluna, Roxana G.

AU - Fuller, Clifton D.

AU - Eng, Tony Y.

AU - Ampil, Federico L.

AU - Thomas, Charles R.

PY - 2011/3

Y1 - 2011/3

N2 - The present study was carried out to evaluate the levels of plasma fibronectin (Fn) in cancer patients undergoing radiation therapy (RT) in correlation with outcomes in terms of radiation toxicity. A total of 26 patients with lung and gastrointestinal (GI) cancer, treated with RT were enrolled in this study. Plasma Fn levels were determined before and following a course of RT. The Radiation Therapy Oncology Group (RTOG) criteria were used to determine the grade of RT toxicity. Statistical analysis utilised the nonparametric Mann-Whitney U-test as well as bivariate linear regression. Pre-RT Fn levels were significantly higher in cancer patients without toxicity (median ± SE) (485.0 ± 87 μg/ml) as compared with the levels of plasma Fn in patients with grade I-II RTOG acute toxicity (354.0 ± 74 μg/ml, p = 0.01). No significant difference in Fn levels was found in patients with grade I toxicity compared with patients with grade II toxicity. In addition, low baseline Fn levels (148 and 299 μg/ml) were observed in two lung cancer patients who developed symptomatic pneumonitis during the first 2 months after RT. These preliminary results suggest that low baseline Fn may have potential as a predictive marker for development of RT-induced toxicity.

AB - The present study was carried out to evaluate the levels of plasma fibronectin (Fn) in cancer patients undergoing radiation therapy (RT) in correlation with outcomes in terms of radiation toxicity. A total of 26 patients with lung and gastrointestinal (GI) cancer, treated with RT were enrolled in this study. Plasma Fn levels were determined before and following a course of RT. The Radiation Therapy Oncology Group (RTOG) criteria were used to determine the grade of RT toxicity. Statistical analysis utilised the nonparametric Mann-Whitney U-test as well as bivariate linear regression. Pre-RT Fn levels were significantly higher in cancer patients without toxicity (median ± SE) (485.0 ± 87 μg/ml) as compared with the levels of plasma Fn in patients with grade I-II RTOG acute toxicity (354.0 ± 74 μg/ml, p = 0.01). No significant difference in Fn levels was found in patients with grade I toxicity compared with patients with grade II toxicity. In addition, low baseline Fn levels (148 and 299 μg/ml) were observed in two lung cancer patients who developed symptomatic pneumonitis during the first 2 months after RT. These preliminary results suggest that low baseline Fn may have potential as a predictive marker for development of RT-induced toxicity.

KW - fibronectin

KW - gastrointestinal cancer

KW - lung cancer

KW - radiation toxicity

UR - http://www.scopus.com/inward/record.url?scp=79952989644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952989644&partnerID=8YFLogxK

U2 - 10.1017/S1460396910000154

DO - 10.1017/S1460396910000154

M3 - Article

AN - SCOPUS:79952989644

VL - 10

SP - 27

EP - 33

JO - Journal of Radiotherapy in Practice

JF - Journal of Radiotherapy in Practice

SN - 1460-3969

IS - 1

ER -